GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B8494 A-381393Summary: An effective, selective, blood-brain barrier-permeable dopamine D4 receptor antagonist -
B8519 NNC-0640Summary: A potent negative allosteric modulator (NAM) of the human glucagon receptor (GCGR) -
B8536 JMS-17-2Summary: An effective selective CX3CR1 small-molecule antagonist -
B8538 Adenosine amine congenerSummary: Selective A1 adenosine receptor agonist -
B8542 Dazoxiben hydrochlorideSummary: An effective and orally active thromboxane synthase inhibitor -
B8546 THPP-1Summary: A potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor -
B8551 p-MPPI hydrochlorideSummary: Selective 5-HT1A receptor antagonist -
B6111 Lu AF21934Summary: positive allosteric modulator of mGlu4 receptors -
B7809 PonesimodSummary: sphingosine-1-phosphate receptor 1 (S1P1) modulator -
B7814 ATI-2341 TFASummary: CXCR4 allosteric agonist
